DEA Processes Siemens Healthcare Diagnostics Bulk Manufacturer Application
February 13, 2026
February 13, 2026
WASHINGTON, Feb. 13 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration announced that Siemens Healthcare Diagnostics Inc., Newark, Delaware, has applied for registration as a bulk manufacturer of a specific Schedule II controlled substance.
The application pertains to the following substance:
* Ecgonine
The applicant intends to produce the substance in bulk for use in the manufacturing of products that are exempt from DEA regulations. . . .
The application pertains to the following substance:
* Ecgonine
The applicant intends to produce the substance in bulk for use in the manufacturing of products that are exempt from DEA regulations. . . .